Fluperlapine

N/A

Report date: 2024/01/25 09:18:08
NME

Base Information

Drug NameFluperlapine
Drug Alias Name氟培拉平NB-106689NB 106-689
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonistsDopamine receptors antagonistsMuscarinic acetylcholine receptor agonists
TargetsSerotonin (5-HT) receptorDopamine receptorsMuscarinic acetylcholine receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksWikipedia